Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Apple
AAPL
|
+$763M |
| 2 |
Amazon
AMZN
|
+$688M |
| 3 |
TSMC
TSM
|
+$562M |
| 4 |
Tesla
TSLA
|
+$419M |
| 5 |
Johnson & Johnson
JNJ
|
+$398M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
Novo Nordisk
NVO
|
+$366M |
| 4 |
JPMorgan Chase
JPM
|
+$335M |
| 5 |
ASML
ASML
|
+$325M |
Sector Composition
| 1 | Healthcare | 20.8% |
| 2 | Technology | 15.52% |
| 3 | Consumer Discretionary | 11.85% |
| 4 | Consumer Staples | 10.11% |
| 5 | Financials | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VBIV
3276
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $268K | ﹤0.01% |
22,881
-7,652
| -25% | -$89.6K |
|
3277
Adicet Bio
ACET
$67.5M
| $266K | ﹤0.01% |
+29,700
| New | +$266K |
|
3278
Milestone Pharmaceuticals
MIST
$167M
| $266K | ﹤0.01% |
+67,200
| New | +$266K |
|
|
OPI
3279
Office Properties Income Trust
OPI
$40.8M
| $266K | ﹤0.01% |
+19,955
| New | +$266K |
|
3280
Arq
ARQ
$306M
| $266K | ﹤0.01% |
109,545
+55,500
| +103% | +$135K |
|
3281
COPT Defense Properties
CDP
$3.46B
| $265K | ﹤0.01% |
+10,200
| New | +$265K |
|
3282
Nektar Therapeutics
NKTR
$926M
| $265K | ﹤0.01% |
+7,807
| New | +$265K |
|
|
RPT
3283
Rithm Property Trust Inc.
RPT
$124M
| $265K | ﹤0.01% |
36,500
+600
| +2% | +$4.36K |
|
3284
Planet Labs
PL
$3.01B
| $264K | ﹤0.01% |
60,800
-231,300
| -79% | -$1M |
|
3285
Healthpeak Properties
DOC
$12.6B
| $263K | ﹤0.01% |
+10,500
| New | +$263K |
|
3286
SPDR Euro Stoxx 50 ETF
FEZ
$4.59B
| $263K | ﹤0.01% |
6,794
-1,706
| -20% | -$66K |
|
3287
The Greenbrier Companies
GBX
$1.42B
| $262K | ﹤0.01% |
+7,800
| New | +$262K |
|
3288
FlexShares STOXX Global Broad Infrastructure Index Fund
NFRA
$2.96B
| $262K | ﹤0.01% |
+5,200
| New | +$262K |
|
|
RDGT
3289
Ridgetech, Inc. Ordinary Shares
RDGT
$7.9M
| $262K | ﹤0.01% |
3,666
-264
| -7% | -$18.9K |
|
|
CVT
3290
DELISTED
Cvent Holding Corp. Common Stock
CVT
| $262K | ﹤0.01% |
48,600
+8,800
| +22% | +$47.4K |
|
3291
Compass Therapeutics
CMPX
$613M
| $261K | ﹤0.01% |
51,900
-12,315
| -19% | -$61.9K |
|
3292
Magnachip Semiconductor
MX
$112M
| $261K | ﹤0.01% |
+27,843
| New | +$261K |
|
3293
Y-mAbs Therapeutics
YMAB
$390M
| $261K | ﹤0.01% |
53,500
-74,400
| -58% | -$363K |
|
3294
Athira Pharma
ATHA
$14.2M
| $260K | ﹤0.01% |
82,100
-152,903
| -65% | -$484K |
|
|
CTO
3295
CTO Realty Growth
CTO
$544M
| $260K | ﹤0.01% |
14,201
-79,500
| -85% | -$1.46M |
|
3296
Talkspace
TALK
$429M
| $260K | ﹤0.01% |
426,010
-74,590
| -15% | -$45.5K |
|
3297
GeoVax Labs
GOVX
$17.8M
| $259K | ﹤0.01% |
27,364
-42,338
| -61% | -$401K |
|
|
NAAS
3298
NaaS Technology Inc
NAAS
$7.26M
| $259K | ﹤0.01% |
208
-48
| -19% | -$59.8K |
|
3299
Equinox Gold
EQX
$8.29B
| $258K | ﹤0.01% |
78,600
-91,200
| -54% | -$299K |
|
3300
Disc Medicine
IRON
$2.08B
| $258K | ﹤0.01% |
12,970
+6,975
| +116% | +$139K |
|